Dr. Hersh is a revered ophthalmic surgeon who has participated in many FDA clinical trials of excimer laser LASIK and other surgical corrections of nearsightedness, farsightedness, astigmatism, and keratoconus. Most prominently, he was lead author of the clinical study that led to the very first FDA approval of laser vision correction for the treatment of nearsightedness in the United States in 1995. He also was one of 2 investigators to present the Conductive Keratoplasty procedure to the FDA device panel, resulting in its 2002 approval. More recently, Dr. Hersh served as medical monitor and was lead author of the two studies leading to U.S. FDA approvals of corneal collagen crosslinking (CXL) for keratoconus and corneal ectasia.
Dr. Hersh has been elected to the American Ophthalmological Society, the oldest and most prestigious eye surgery association in the country. He has also been awarded the Senior Honor Award from the American Academy of Ophthalmology, an honor bestowed on fewer than 1% of eye surgeons, and has been selected for Best Doctors in America for over 10 years running. Due to his philanthropic work, he was awarded a Paul Harris Fellowship from Rotary International.